Does an innovative method of sequencing, known as next generation sequencing (NGS), applied for normal embryo selection in infertile patients improve pregnancy rate in fresh transfer?

Not Applicable

Active, not recruiting

• Conditions: embryo aneuploidy; Reproductive Health and Childbirth - Fertility including in vitro fertilisation; infertility

• Registration Number: ACTRN12614001035617
• Lead Sponsor: Invicta s. z o.o.

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2014-09-25
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Active, not recruiting
• Sex: All
• Target Recruitment: 98

Inclusion Criteria

1. Patients undergoing intracytoplasmic sperm injection (ICSI) in Invicta Fertility and Reproductive Centre s. z o.o. in time frame from 08.2013 to 01.2014
2. At least two previous implantation failures

Exclusion Criteria

1. Patients with endometriosis or adenomiosis
2. Patients with problems related to endometrium thickness

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
pregnancy rate (as ultrasound fetal heartbeat detection)[on 6 weeks and 1-3 days post embryo transfer]

Secondary Outcome Measures

Name	Time	Method
implantation rate (by transvaginal ultrasound)[5 weeks and 3 days +/- 2 days post embryo transfer];miscarriage rate (ultrasound)[up to 12 weeks post embryo transfer]